Results 161 to 170 of about 272,016 (336)
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić +4 more
wiley +1 more source
Calidad del agua para riego: situación histórica y actual del río Colorado (Comunicación breve)
La calidad del agua para riego está condicionada por las sales (cantidad y tipo) y sedimentos que la constituyen. Las características del agua destinada al riego influyen en las propiedades edáficas, el rendimiento de los cultivos, las obras del sistema ...
Maria Luján Masseroni +4 more
doaj
Dynamically frequency‐tunable and environmentally stable microwave absorbers
The threat to information security from electromagnetic pollution has sparked widespread interest in the development of microwave absorption materials (MAMs).
Xiao Liu +8 more
doaj +1 more source
Sonetti inediti del conte Giovanni Pico della Mirandola, messi in luce dal sac.
"Ricordo del quarto centenario dalla morte di Giovanni Pico salutato fenice degli ingegni."Mode of access ...
Pico della Mirandola, Giovanni, 1463-1494.
core
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani +4 more
wiley +1 more source
Vita, fattezze e morte di Giovanni Pico della Mirandola, per la prima volta studiate congiuntamente da uno storico e da un antropologo, al fine di rileggere, sulla base di documenti inediti e di nuove metodiche di indagine, la vicenda umana e ...
GRUPPIONI, GIORGIO, ANDREOLLI, BRUNO
core +1 more source
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk +5 more
wiley +1 more source
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
Regulatory harmonization: Evolution, globalization and future directions
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm +2 more
wiley +1 more source

